1 study found for:    NCT00703924
Show Display Options
Rank Status Study
1 Completed Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World
Condition: Cutaneous Leishmaniasis
Interventions: Drug: WR 279,396;   Drug: Placebo

Indicates status has not been verified in more than two years